TEL AVIV, Israel, Dec. 10, 2025 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) today announced that its pharmaceutical division has completed an R&D assessment of LayerBio’s proprietary drop-less, ...

PainReform ( (PRFX)) has shared an announcement. On December 10, 2025, PainReform Ltd. announced the successful R&D assessment of its LayerBio drop-less, sustained-release ocular platform, confirming ...

As Enugu State and the wider educational community celebrate the birthday of Ernest Ike Ugwu, it is impossible to overlook the profound imprint he has made across education, technology, cooperative ...

Susan Bard, MD, is a board-certified general and procedural dermatologist with the American Board of Dermatology and a Fellow of the American College of Mohs Surgery. Cleansing, moisturizing, and ...

PainReform (PRFX) announced that its pharmaceutical division has completed an R&D assessment of LayerBio’s proprietary drop-less, sustained-release ocular drug-delivery platform. The assessment ...